Koyfin Home > Directory > Health Care > Adma Biologics > Price / Earnings (ntm)

Adma Biologics Price / Earnings (ntm) Chart (ADMA)

Adma Biologics annual/quarterly Price / Earnings (ntm) from 2020 to 2020. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
Other Valuation Metrics:
  • Adma Biologics Market Cap for the quarter ending March 03, 2018 was $208m a 54.25% increase of 113m year over year
  • Adma Biologics Price / Book for the quarter ending March 03, 2018 was 5.17 a -360.96% decrease of -18.66 year over year
  • Adma Biologics Enterprise Value for the quarter ending March 03, 2018 was $206m a 49.35% increase of 101m year over year
View Chart On Koyfin